ArticleScientific reports2026
Autism spectrum disorder identification using machine learning models on MRI data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects sensory processing, speech, behavior and identifying the condition at an early stage is necessary to provide the treatment. The existing diagnostic methods are mainly based on personalized subjective and time consuming. This study introduces an objective diagnostic method by analyzing technical noise signature producing the Quality Vector which is extracted from multimodal MRI data. This work leverages Machine Learning (ML) and Deep Learning (DL) techniques on this Quality vector for improving ASD detection. The methodology leveraged technical Quality Assessment Protocol (QAP) metrics from the ABIDE II repository, integrating structural (sMRI), functional (fMRI), and diffusion (DTI) modalities. The methodology utilized Density-Based Spatial Clustering of Applications with Noise (DBSCAN) for outlier removal and Principal Component Analysis (PCA) for dimensionality reduction. A classification pipeline was implemented using a 1D-Residual Network (1D-ResNet), Convolutional Neural Network(CNN), SVM, kNN and a proposed Voting Ensemble (SVM, KNN, and XGBoost), validated through stratified 10-fold cross-validation. In this work, the proposed ensemble emerged as the superior model, achieving a diagnostic accuracy of 95.84%. These findings indicate that technical biomarkers derived from imaging quality metrics are highly useful for ASD detection. This research demonstrates that technical quality metrics, often dismissed as noise, contain significant diagnostic value. The Quality Vector framework provides a computationally efficient and objective tool for ASD identification. The high classification performance suggests that the biomarkers obtained from MRI have a potential future scope in research on early ASD diagnosis and detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.